Veterinary Medicines

Canaural eyrnadropar, dreifa

Authorised
  • Prednisolone
  • Nystatin
  • Framycetin sulfate
  • Diethanolamine fusidate
Download as PDF

Product identification

Medicine name:
Canaural eyrnadropar, dreifa
Active substance:
  • Prednisolone
  • Nystatin
  • Framycetin sulfate
  • Diethanolamine fusidate
Target species:
  • Dog
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Prednisolone
    2.35
    milligram(s)
    /
    1.00
    millilitre(s)
  • Nystatin
    94000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Framycetin sulfate
    4.70
    milligram(s)
    /
    1.00
    millilitre(s)
  • Diethanolamine fusidate
    4.70
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Ear drops, suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Iceland
Available in:
  • Iceland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Dechra Veterinary Products A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera Research Ltd.
  • Dales Pharmaceuticals Limited
Responsible authority:
  • Icelandic Medicines Agency
Authorisation number:
  • 822774
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Icelandic (PDF)
Published on: 1/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Icelandic (PDF)
Published on: 1/03/2022
Updated on: 31/01/2025
Download